Table 5 Cox Proportional Hazards Model of Overall Survival for patients with local disease:
From: Breast cancer in moroccan young women: a retrospective study
| Â | Univariate analysis | Â | Multivariate analysis | Â | ||
|---|---|---|---|---|---|---|
| Â | Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value |
Family history | Â | Â | Â | Â | Â | Â |
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 1.10 | 0.47 - 2.58 | 0.83 | 1.12 | 0.44-2.88 | 0.81 |
SBR grading | ||||||
SBR I | 1.00 | Â | Â | 1.00 | Â | Â |
SBR II | 2.01 | 0.27 - 14.6 | 0.49 | 1.26 | 0.15-10.9 | 0.83 |
SBR III | 2.55 | 0.35 - 18.69 | 0.36 | 1.03 | 0.12-8.76 | 0.97 |
Tumor size | ||||||
T1 | 1.00 | Â | Â | 1.00 | Â | Â |
T2 | 1.54 | 0.65 - 3.66 | 0.33 | 2.25 | 0.50-10.19 | 0.30 |
T3 | 1.55 | 0.59 - 4.1 | 0.38 | 2.50 | 0.47-13.42 | 0.29 |
T4 | 1.64 | 0.64 - 4.23 | 0. 31 | 2.34 | 0.44-12.44 | 0.32 |
N statut | ||||||
N- | 1.00 | Â | Â | 1.00 | Â | Â |
N+ | 0.78 | 0.47 - 1.28 | 0.32 | 0.62 | 0.29-1.30 | 0.20 |
Stage | Â | Â | Â | |||
I | 1.00 | Â | Â | 1.00 | Â | Â |
II | 2.10 | 0.53 - 8.37 | 0.29 | 1.43 | 0.24-8.57 | 0.69 |
III | 4.24 | 1.1 - 16.28 | 0.03 | 3.56 | 0.65-19.57 | 0.14 |
ER | ||||||
ER positive | 1.00 | Â | Â | 1.00 | Â | Â |
ER negative | 2.25 | 1.37 - 3.72 | 0.001 | 2.54 | 1.32- 4.90 | 0.005 |
Adjuvant chemotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.49 | 0.24 - 0.99 | 0.04 | 0.74 | 0.18-3.05 | 0.68 |
Adjuvant hormonotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.45 | 0.28 - 0.73 | 0.001 | 0.89 | 0.45-1.77 | 0.74 |
Surgery type | ||||||
Radical mastectomy | 1.00 | Â | Â | 1.00 | Â | Â |
Conserving surgery | 0.64 | 0. 34 - 1.23 | 0.17 | 0.50 | 0.19-1.18 | 0.11 |
Adjuvant radiotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.42 | 0.24-0.74 | 0.003 | 0.74 | 0.25-2.23 | 0.60 |